Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2025-01-22 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2024年度业绩预告
Earnings Release Classification · 95% confidence The document is a 2024年度业绩预告, which translates to a 2024 performance forecast or earnings guidance. It provides estimated financial results for the full year 2024, including expected net profit/loss and earnings per share, but it explicitly states that the data is preliminary, unaudited, and based on internal estimates. It also includes a risk warning that the final financial data will be disclosed in the 2024 annual report. The document is short (926 characters) and serves as an initial announcement of expected financial results rather than a full financial report. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly or periodical financial results with key highlights only. FY 2024
2025-01-22 Chinese
关于与专业投资机构共同投资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an investment by the company and its subsidiary into a joint venture fund with professional investment institutions. It details the investment overview, parties involved, fund structure, investment scope, management fees, profit distribution, risks, and other related information. There is no indication that this is a full financial report, audit report, earnings release, or regulatory filing. The document is a detailed announcement about a capital investment transaction and partnership, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains detailed information about the financing arrangement, not just a brief notice or a report publication announcement.
2024-12-30 Chinese
关于控股股东所持公司部分股份将被司法拍卖的提示性公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the judicial auction of shares held by the company's controlling shareholder. It details the number of shares to be auctioned, the reasons for the auction (a stock pledge dispute), and the potential risks to the company's control and governance. There are no financial statements, management discussions, or detailed financial data. The document is relatively short (2318 characters) and serves as a notification of a significant event affecting shareholding and control risks. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a legal/financial event impacting the company but does not qualify as a full financial report or other specific filing types.
2024-12-27 Chinese
关于控股股东股份被司法再冻结的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding the judicial re-freezing of shares held by its controlling shareholders. It details the number of shares frozen, the proportion of total shares affected, and the associated risks. There is no financial data, no discussion of financial results, no mention of a report being attached or published, and no indication of a meeting or voting results. The content is a regulatory announcement about shareholding status and legal restrictions on shares. This fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-11 Chinese
关于控股股东被动减持实施期限届满暨实施结果的公告
Director's Dealing Classification · 95% confidence The document is an announcement regarding the completion of a passive share reduction by a controlling shareholder due to a stock pledge default. It details the number of shares reduced, the price range, and confirms compliance with regulatory requirements. There are no financial statements or detailed financial performance data. The document is a formal disclosure of a shareholder's transaction in the company's shares, specifically a passive reduction of shares held by a director or controlling shareholder. This fits the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this transaction, with no indication of it being a full financial report or other type of filing.
2024-10-31 Chinese
关于控股股东之一致行动人所持公司部分股份司法拍卖中止的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the suspension of a judicial auction of shares held by a controlling shareholder's concert party. It does not contain financial statements, management discussion, or detailed financial data. It is an update on a legal/financial event affecting shareholding but not a full report or detailed filing. The document length is only 519 characters, indicating it is a brief announcement. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-10-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.